An international common data model for improving medicine management for people with dementia and comorbid conditions.
Australia’s Clinical Practice Guidelines and Principles of Care for People with Dementia highlight the importance of providing evidence-based care to improve quality of life, maintain function and maximise comfort. However, clinicians do not necessarily prescribe the same guideline-recommended medicines for people with and without dementia. Indeed, people with dementia are often excluded from randomised controlled trials. Fortunately, recent and widespread availability of electronic prescribing and dispensing data are transforming medicine safety and effectiveness research. We propose to develop the first large-scale international common data model (CDM) specifically for people with dementia. A CDM is a data platform that supports secondary use of linked health data through standardising definitions, terminologies, vocabularies and coding schemes. Using the CDM, we will conduct analyses of linked Australian, Hong Kong, UK and US data to generate new evidence regarding medicine safety and effectiveness for people with dementia. This will help fill a critical evidence gap.
Prof Bell is a National Health and Medical Research Council Dementia Leadership Fellow, Centre for Medicine Use and Safety, Monash University. He is also Adjunct Professor of Geriatric Pharmacotherapy, Faculty of Health Sciences, University of Eastern Finland; Adjunct Associate Professor, School of Public Health and Preventive Medicine, Monash University and Adjunct Associate Professor, School of Pharmacy and Medical Sciences, University of South Australia.